Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1465-1478
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1465
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1465
Figure 1 Human β-defensin-1 affects the viability, clonogenesis, and autophagy of SW620 cells.
A: Human β-defensin-1 (hBD-1) suppresses cell viability; B: hBD-1 inhibits clonal formation; C: Clonal formation count; D: hBD-1 inhibits phosphorylation of mTOR and promotes expression of Beclin-1 and LC3II/I; E-G: Relative expression of p-mTOR, Beclin-1, and LC3II/I. aP < 0.05 vs control group. hBD-1: Human β-defensin-1.
- Citation: Zhao YX, Cui Y, Li XH, Yang WH, An SX, Cui JX, Zhang MY, Lu JK, Zhang X, Wang XM, Bao LL, Zhao PW. Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506. World J Gastrointest Oncol 2024; 16(4): 1465-1478
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1465.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1465